{"id":"W2611131029","doi":"10.1056/nejmoa1614949","title":"Teprotumumab for Thyroid-Associated Ophthalmopathy","year":2017,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Ophthalmology and Eye Disorders","field":"Medicine","cited_by":721,"is_retracted":false,"has_abstract":true,"ca_institutions":"Kellogg's (Canada)","funders":"National Institute of Allergy and Infectious Diseases; National Eye Institute; National Institute of Diabetes and Digestive and Kidney Diseases; U.S. Food and Drug Administration","keywords":"Medicine; Graves' ophthalmopathy; Placebo; Internal medicine; Adverse effect; Thyroid; Population; Clinical trial; Clinical endpoint; Graves' disease; Gastroenterology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004607686,0.0003555488,0.0007657394,0.0001064897,0.0002082166,0.0002533416,0.0002061064,0.0003433229,0.001783618],"category_scores_gemma":[0.0004639419,0.0001037996,0.0003716792,0.00009259694,0.0002284775,0.0001397669,0.0001170464,0.0006697375,0.0002452869],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002418131,"about_ca_system_score_gemma":0.0003562462,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002871315,"about_ca_topic_score_gemma":0.0007495633,"domain_scores_codex":[0.9998708,0.00004607594,0.00001091229,0.00002491934,0.00002519491,0.00002210383],"domain_scores_gemma":[0.9997516,0.00008149926,0.00007619807,0.00001228868,0.00001578789,0.00006274132],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2596137,0.0071353,0.02053705,0.003629084,0.001326777,0.002185071,0.0003218686,0.001729513,0.1344407,0.0004193948,0.007614155,0.5610473],"study_design_scores_gemma":[0.4014533,0.3747739,0.1414097,0.0007078716,0.002477564,0.01471592,0.0002074419,0.004917498,0.02735596,0.0005279277,0.03137534,0.00007748589],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9806107,0.01603893,0.0004293912,0.0004179669,0.0001535558,0.0003270401,0.0001027813,0.00004479204,0.001874797],"genre_scores_gemma":[0.9949834,0.003046294,0.0005673866,0.000349953,0.0001576871,0.0001730283,0.000085147,0.000003979443,0.0006330982],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001783618,"threshold_uncertainty_score":0.005966783,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04452435748877569,"score_gpt":0.3543494066987863,"score_spread":0.3098250492100106,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}